Hot Cross-linking (Iqbal CXL) - Trial PACTR201902485435341
Access comprehensive clinical trial information for PACTR201902485435341 through Pure Global AI's free database. This Not Applicable trial is sponsored by MOHAMMED IQBAL; Ahmed Elmassry and is currently Recruiting. The study focuses on Eye Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
procedure
Sponsor & Location
MOHAMMED IQBAL; Ahmed Elmassry
Mohammed Iqbal
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
Cornea Is resistant to destruction by cold (up to -70°C) and heat (up to +80°C). lowering the corneal temperature before CXL may increase oxygen diffusion into the cornea thus increasing CXL efficacy. However, the new idea of hot CXL proposed by Professor Mohammed Iqbal is to increase the corneal temperature during CXL to reach from 38°C to 39°C to test the corneal behavior and response to CXL in such high temperature.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201902485435341
Non-Device Trial